Northern Trust’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Sell |
512,234
-15,075
| -3% | -$37.2K | ﹤0.01% | 3258 |
|
|
2025
Q1 | $1.05M | Sell |
527,309
-17,628
| -3% | -$35.1K | ﹤0.01% | 3251 |
|
|
2024
Q4 | $1.59M | Buy |
544,937
+20,389
| +4% | +$59.5K | ﹤0.01% | 3147 |
|
|
2024
Q3 | $2.03M | Buy |
524,548
+131,031
| +33% | +$507K | ﹤0.01% | 2994 |
|
|
2024
Q2 | $2.02M | Buy |
393,517
+53,519
| +16% | +$275K | ﹤0.01% | 2890 |
|
|
2024
Q1 | $2.38M | Sell |
339,998
-4,929
| -1% | -$34.5K | ﹤0.01% | 2868 |
|
|
2023
Q4 | $3.06M | Buy |
344,927
+11,969
| +4% | +$106K | ﹤0.01% | 2763 |
|
|
2023
Q3 | $3.18M | Buy |
332,958
+50,527
| +18% | +$482K | ﹤0.01% | 2687 |
|
|
2023
Q2 | $4.14M | Buy |
282,431
+192,352
| +214% | +$2.82M | ﹤0.01% | 2601 |
|
|
2023
Q1 | $1.11M | Buy |
90,079
+6,533
| +8% | +$80.4K | ﹤0.01% | 3188 |
|
|
2022
Q4 | $1.55M | Buy |
+83,546
| New | +$1.55M | ﹤0.01% | 3114 |
|